Daclatasvir Plus Peginterferon and Ribavirin Is Noninferior to Peginterferon and Ribavirin Alone, and Reduces the Duration of Treatment for HCV Genotype 2 or 3 Infection

Overview of attention for article published in Gastroenterology, October 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,459 followers.

Daclatasvir + PegIFN/RBV Is Noninferior to PegIFN/RBV, and Reduces the Duration of Tx for HCV Gen 2 or 3 Gastroenter http://t.co/ZIKlTz5pv2

Daclatasvir+PegIFN+RBV is non-inferior to PegIFN+RBV alone and reduces duration of treatment for HCV GT2-3 infection. http://t.co/NX8F27llQr

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.